% 11.9% Debt to Equity ratio 0.09 0.14 Earnings per share 0.90 0.53 ROA 19.6% 12.9% ROE 21.4% 13.5% Gross profit margin = Gross Profit (Total Sales – Costs of Sales) to Sales Net profit margin = Net Profit
margin 25.3% 18.1% Net profit margin 17.6% 11.9% Debt to Equity ratio 0.17 0.10 Earnings per share 0.66 0.46 ROA 13.1% 11.0% ROE 14.0% 10.9% Gross profit margin = Gross Profit (Total Sales – Costs of Sales
) (100.0) Total comprehensive income for the year 88,483 101,918 104,394 (15,911) (15.2) Gross Profit Margin 25.2% 23.4% 22.4% 2.8% - Basic earnings per share (Baht/Share) 0.22 0.26 0.26 (0.04) (14.9) Net
) - (354) (100.0) Total comprehensive income for the year 88,483 101,918 104,394 (15,911) (15.2) Gross Profit Margin 25.2% 23.4% 22.4% 2.8% - Basic earnings per share (Baht/Share) 0.22 0.26 0.26 (0.04) (14.9
1,494 8% EBITDA Bio-Based Product Business4/ 113 179 59 -48% -67% 259 238 -8% EBITDA Resource Business5/ 59 133 93 58% -30% 81 226 181% EBITDA Others 6/ (25) (25) (12) 54% 53% (25) (37) -48% Profit
(losses) on financial instruments measured at the fair value through profit or loss, gains on investments, dividend income and other operating incomes. In the first quarter of 2021, net non-interest income
Highlights - FY19 Net profit* was at THB 3,259 million (+8.4% YoY), with net profit* margin of 12.7% (+30 bps YoY), where the improvement mainly came from growth in revenues of core businesses and favorable
may not always tally with consolidated financials due to holding segment. 3Core EBITDA is Reported EBITDA less Inventory gains/(losses). 4Core Net Profit is Reported Net Profit less Inventory gains
tally with consolidated financials due to holding segment. 3Core EBITDA is Reported EBITDA less Inventory gains/(losses). 4Core Net Profit is Reported Net Profit less Inventory gains/(losses) and one-time